The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

  • This share is currently suspended. It was suspended at a price of 38.80

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: -38.80 (-100.00%)
Open: 38.80
High: 38.80
Low: 38.80
Prev. Close: 38.80
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of ESG Report

28 Sep 2021 09:46

RNS Number : 2134N
Accrol Group Holdings PLC
28 September 2021
 

 

Reach

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Launch of Environmental, Social and Governance Report

 

Accrol, the UK's leading independent tissue converter, is pleased to announce that it has today published its first Environmental, Social and Governance ("ESG") Report, which is available on the Group's website: https://www.accrol.co.uk/esg/  

 

The report sets out the Group's vision for ESG and how it intends to achieve its goals, using clear targets and KPIs and a reporting framework against which progress will be demonstrated.

 

Gareth Jenkins, Chief Executive Officer of Accrol, said:

 

"Accrol's vision is to be a carbon neutral business that improves the lives of its people and communities, while working in partnership with suppliers to deliver sustainable products to customers and consumers and consistent results to our investors.

 

In this, our first sustainability report, we have detailed the actions we are currently taking and how we expect these to benefit both our business and our stakeholders. It also outlines what we plan to do next. Our relentless approach to operational excellence in the business applies equally to ESG and we will use this framework to measure our progress and showcase our performance over time."

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Richard Newman, Chief Financial Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

 

 

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

 

 

 

Belvedere Communications Limited

 

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

 

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.

 

For more information, please visit www.accrol.co.uk

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPUPCBUPGURR
Date   Source Headline
20th Jan 20207:00 amRNSRegulatory investigation closed
15th Jan 20207:00 amRNSTR-1
14th Jan 20207:00 amRNSTR-1
7th Jan 20207:00 amRNSHalf Year Results
16th Dec 20197:00 amRNSTR-1
13th Nov 201912:11 pmRNSTR-1
22nd Oct 201911:30 amRNSResult of AGM
17th Oct 20198:00 amRNSVesting of FY2019 Share Option Awards
26th Sep 20198:30 amRNSNotice of AGM
6th Sep 201911:52 amRNSTR-1
3rd Sep 20197:00 amRNSAudited Final Results
10th Jun 20197:00 amRNSTrading Update and Notice of Results
25th Apr 20194:32 pmRNSDirector/PDMR Shareholding
10th Apr 20197:00 amRNSSenior Management Change
27th Mar 201910:20 amRNSRegulatory Investigation Update
11th Feb 20194:35 pmRNSDirector/PDMR Shareholding
6th Feb 20193:03 pmRNSHolding(s) in Company
22nd Jan 20195:15 pmRNSDirector's Dealing
22nd Jan 20199:05 amRNSSecond Price Monitoring Extn
22nd Jan 20199:00 amRNSPrice Monitoring Extension
22nd Jan 20197:01 amRNSHalf Year Results
22nd Jan 20197:00 amRNSBoard Change and Senior Management Appointment
21st Jan 20192:20 pmRNSRegulatory Investigation
10th Jan 20191:35 pmRNSHolding(s) in Company
8th Jan 201911:05 amRNSSecond Price Monitoring Extn
8th Jan 201911:00 amRNSPrice Monitoring Extension
8th Jan 20197:00 amRNSTrading Update
23rd Nov 20187:00 amRNSAccrol Group to present at Mello London
30th Oct 201811:37 amRNSResult of AGM
30th Oct 20187:00 amRNSPDMR Dealings
29th Oct 201811:24 amRNSBoard and Board Committee Changes
10th Oct 20187:00 amRNSAppointment of Non Executive Director
28th Sep 20187:00 amRNSAudited Final Results and Notice of AGM
26th Sep 20187:00 amRNSUnaudited Final Results 2018 and Banking Update
28th Aug 20187:00 amRNSBoard and Senior Management Changes
11th Jul 20187:00 amRNSNotice of Final Results
11th Jul 20187:00 amRNSDirectorate Change
9th Jul 20184:04 pmRNSHolding(s) in Company
18th Jun 20184:39 pmRNSDirector's Dealings
18th Jun 20187:00 amRNSHolding(s) in Company
12th Jun 20183:47 pmRNSDirectors' Dealings
12th Jun 20187:00 amRNSAccrol Leads the Way with Plastic-free Packaging
11th Jun 20187:00 amRNSAppointment of Chief Financial Officer
7th Jun 20187:00 amRNSResult of Open Offer
4th Jun 20182:20 pmRNSHolding(s) in Company
4th Jun 20187:00 amRNSHolding(s) in Company
1st Jun 20188:01 amRNSDirectors' Dealings
1st Jun 20188:00 amRNSPlacing Shares Admitted and Total Voting Rights
31st May 201811:35 amRNSResult of General Meeting
22nd May 20186:25 pmRNSPosting of Cricular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.